Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab in Uncontrolled Severe Asthma (China phase 3)
CTR20170780Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Jul 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by Kyowa Kirin. Started Jul 2017; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20170780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170780.